US2007032694A1PendingUtilityA1

Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxis

Assignee: DINKELBORG LUDGERPriority: Apr 30, 1997Filed: Nov 24, 2003Published: Feb 8, 2007
Est. expiryApr 30, 2017(expired)· nominal 20-yr term from priority
A61L 2300/606A61L 31/16A61L 31/18A61L 2300/44A61L 31/14A61K 51/1282A61L 2300/416A61N 5/1002A61F 2210/0095A61L 31/082A61F 2/82A61K 51/12A61L 33/00
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to radioactive stents, characterized in that the stent is coated on the surface with the radioactive isotope, as well as processes for their production.

Claims

exact text as granted — not AI-modified
1 - 9 . (canceled)  
     
     
         10 . A radioactive stent comprising a radioactive isotope that is fixed on the surface of the stent by an adhesive that is solely a peptide, or a peptide bound to a radioactive isotope complexing agent, a fat bound to a radioactive isotope complexing agent, or gold bound to a thiol-group-containing radioactive isotope complexing agent.  
     
     
         11 . A radioactive stent according to  claim 10 , wherein the radioactive isotope is one or more of Ag, Au, Ba, Bi, C, Co, Cr, Cu, Fe, Gd, Hg, Ho, In, Ir, Lu, Mn, Ni, P, Pb, Pd, Pm, Pt, Re, Rh, Ru, S, Sb, Sc, Sm, Th, Tc or Y.  
     
     
         12 . A radioactive stent according to  claim 10 , wherein the adhesive is a peptide.  
     
     
         13 . A radioactive stent according to  claim 10 , wherein the adhesive is a peptide bound to a radioactive isotope complexing agent.  
     
     
         14 - 28 . (canceled)  
     
     
         29 . A radioactive stent according to  claim 10 , wherein the adhesive is gold bound to a thiol-group-containing radioactive isotope complexing agent.  
     
     
         30 . A radioactive stent according to  claim 10 , wherein the adhesive is a fat bound to a radioactive isotope complexing agent.  
     
     
         31 . A radioactive stent comprising a radioactive isotope that is fixed on the surface of the stent by an adhesive consisting essentially of a peptide, or a peptide bound to a radioactive isotope complexing agent, a fat bound to a radioactive isotope complexing agent, or gold bound to a thiol-group-containing radioactive isotope complexing agent.

Join the waitlist — get patent alerts

Track US2007032694A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.